Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Analysts still see osteoporosis drug as key to Amgen's future revenue growth
Analysts still see osteoporosis drug as key to Amgen's future revenue growth
Analysts still see osteoporosis drug as key to Amgen's future revenue growth
Submitted by
admin
on January 27, 2009 - 9:42am
Source:
Yahoo/AP
News Tags:
osteoporosis
Amgen
denosumab
Headline:
Analysts still see osteoporosis drug as key to Amgen's future revenue growth
Do Not Allow Advertisers to Use My Personal information
